Ind Swift Ltd
NSE:INDSWFTLTD

Watchlist Manager
Ind Swift Ltd Logo
Ind Swift Ltd
NSE:INDSWFTLTD
Watchlist
Price: 15.71 INR 5.79%
Market Cap: 850.9m INR

Ind Swift Ltd
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Ind Swift Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Ind Swift Ltd
NSE:INDSWFTLTD
Long-Term Debt
₹10.1B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
6%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Debt
₹11.6B
CAGR 3-Years
86%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Debt
₹3B
CAGR 3-Years
24%
CAGR 5-Years
-34%
CAGR 10-Years
3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Debt
₹3.6B
CAGR 3-Years
-7%
CAGR 5-Years
-27%
CAGR 10-Years
-17%
Lupin Ltd
NSE:LUPIN
Long-Term Debt
₹20.3B
CAGR 3-Years
102%
CAGR 5-Years
151%
CAGR 10-Years
39%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Debt
₹12.4B
CAGR 3-Years
-20%
CAGR 5-Years
-19%
CAGR 10-Years
-6%
No Stocks Found

Ind Swift Ltd
Glance View

Market Cap
850.9m INR
Industry
Pharmaceuticals

Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm operates in both domestic and export markets. The company is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The firm is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. The company operates through various divisions, such as Herba Plus Division, Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Herba Plus Division is engaged in the manufacturing of ayurvedic and pharmaceutical products, such as general category formulations, beta lactam, steroids and hormones, cephalosporins, oncological, soft gelatin capsules, and herbal and nutraceuticals. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte.

INDSWFTLTD Intrinsic Value
Not Available

See Also

What is Ind Swift Ltd's Long-Term Debt?
Long-Term Debt
10.1B INR

Based on the financial report for Mar 31, 2024, Ind Swift Ltd's Long-Term Debt amounts to 10.1B INR.

What is Ind Swift Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
6%

Over the last year, the Long-Term Debt growth was 150%. The average annual Long-Term Debt growth rates for Ind Swift Ltd have been 16% over the past three years , 9% over the past five years , and 6% over the past ten years .

Back to Top